Genentech News
Most Popular Genentech Story
Roche, Pfizer win FDA nods for targeted cancer drugs
Roche ($RHHBY) and Genentech won a landmark approval for the cancer drug vismodegib today. After gaining significant efficacy data from a Phase II study on basal cell carcinoma, the drug giant not Read more...
Latest Headlines
- January 30, 2012
- January 3, 2012
- December 9, 2011
- December 5, 2011
- November 16, 2011
- September 16, 2011
- September 7, 2011
- September 2, 2011
- August 31, 2011
- August 9, 2011
- August 8, 2011
- July 1, 2011
- June 3, 2011
- April 29, 2011
- April 28, 2011
- April 8, 2011
- April 5, 2011
- March 28, 2011
- February 25, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
